We describe a 4-month-old child who developed unusual thrombotic complications following allogeneic BMT for Omenn syndrome, a form of SCID. Eight weeks after the procedure the child suffered a major cerebrovascular accident and developed acute pulmonary hypertension in association with persistently elevated anticardiolipin antibody titres. It is postulated that central line-derived microemboli caused these serious thrombotic complications in the context of an evolving hypercoaguable state. Keywords: anticardiolipin antibodies; bone marrow transplantation; Omenn syndrome; central venous catheter Omenn syndrome was first described in 1965 as familial reticuloendotheliosis with hypereosinophilia in a child with a widespread exfoliative skin eruption, hepatosplenomegaly and failure to thrive.
Omenn syndrome was first described in 1965 as familial reticuloendotheliosis with hypereosinophilia in a child with a widespread exfoliative skin eruption, hepatosplenomegaly and failure to thrive. 1 It is probably a form of 'leaky' SCID with expansion of autoreactive peripheral T cells which infiltrate skin and other organs. 2 BMT is the only curative treatment available. 3 Here, we describe a child with Omenn syndrome who underwent successful BMT from a matched sibling at the age of 4 months. However, the post-transplant period was complicated by a left middle cerebral artery stroke and severe pulmonary hypertension in association with raised anticardiolipin antibody titres. We hypothesise that on a background of an evolving hypercoaguable state, central line-related microemboli caused pulmonary hypertension leading to right to left cardiac shunting across a patent foramen ovale and subsequent thromboembolic phenomenon in the left middle cerebral artery.
Case report
A male infant, weighing 3.3 kg was born to healthy nonconsanguineous Caucasian parents at full term and without complication. At 5 weeks of age he required hospital admission for high fever and was treated with intravenous antibiotics. A septic screen was negative and he was noted to have a widespread eczematous rash and generalised lymphadenopathy. At 8 weeks first immunisations against diptheria, tetanus, pertussis, Haemophilus influenzae type b and polio were given as scheduled. At 11 weeks he developed respiratory distress and was successfully treated for interstitial pneumonia, presumably caused by Pneumocystis carinii, with high-dose cotrimoxazole (120 mg/ kg/day). Immunological investigations revealed hypogammaglobulinaemia and profoundly low B cell numbers in association with grossly elevated IgE levels and hypereosinophilia (Table 1) . T cell responses to the mitogen phytohaemagglutinin were universally low and a substantial proportion of CD3 cells were negative for CD4 and CD8 (double negative T cells) suggesting a 'leaky' form of SCID. Fluorescent in situ hybridisation studies (FISH) detected 100% XY mononuclear and polymorphonuclear cells and thereby excluded maternal engraftment. The diagnosis of Omenn syndrome was made.
The dermatitis and lymphadenopathy responded to treatment with 1 mg/kg/day prednisolone. Tissue typing revealed that his healthy 2-year-old sister was genotypically HLA matched. A right subclavian double lumen Hickmann line was inserted and after preconditioning with Campath 1G (total dose 0.6 mg/kg), BU (total dose 20 mg/kg) and CY (total dose 200 mg/kg) BMT was performed. Prophylaxis against GVHD consisted of intravenous CsA (3 mg/kg/day) and MTX (10 mg/m 2 on days 3, 6 and 11 post transplant). Broad-spectrum antibiotics and amphotericin were given for febrile neutropenia in the peritransplant period and nutritional support with total parenteral nutrition (TPN) was added for 5 days. Granulocyte colonystimulating factor (5 g/kg) was given from day 8 to day 18 after the transplant with neutrophils reaching 0.5 × 10 9 /l by day 15. Intravenous Ig (0.5 g/kg/week) was given for 8 weeks after BMT. On day 15 post transplant abdominal distension with moderate hepatomegaly and mildly raised transaminases were suggestive of veno-occlusive disease which resolved spontaneously. Persistent hypertension was treated with nifedipine. Echocardiography at the time was normal. By day 17 FISH studies for cells exhibiting XX chromosomes (female donor) demonstrated Ͼ95% engraftment. Mild skin GVHD of the palms and soles was evident by day 22 and responded to treatment with a short course of methylprednisolone (2 mg/kg/day). He was discharged home 41 days after transplantation.
Three weeks later (day 59) he developed a high fever, right-sided focal seizures and right hemiplegia. Cranial imaging revealed widespread cerebral infarction in the territory supplied by the left middle cerebral artery (Figure 1 ). A septic screen was negative. Over the following week cen- tral cyanosis and severe oxygen dependency developed. Echocardiography demonstrated pulmonary hypertension with the right ventricle at systemic pressures, and the presence of a patent foramen ovale with right to left shunting. Although ventilation/perfusion scanning did not reveal any major mismatches suggestive of pulmonary embolism, the Hickmann line was removed as a potential source of microemboli. Thrombophilia screen revealed raised anticardiolipin titres (Table 2 ) and reduced antithrombin III and protein S levels. Anticoagulation was initiated using heparin (100 units/kg/twice daily) and warfarin (100 g/kg/day). Complete resolution of oxygen dependency followed within 10 days. Anticardiolipin antibody levels in the donor were found to be normal and retrospective analysis of stored serum from the patient revealed low pre-transplant titres. Other autoantibodies, including the anti-double-stranded DNA antibodies associated with systemic lupus erythematoses, were not detected.
By 4 months post BMT haematological and immunological reconstitution was complete and the antithrombin III and protein S levels had normalised. Follow-up echocardiography showed resolution of the pulmonary hypertension and closure of the patent foramen ovale. Anticardiolipin antibodies normalised by 6 months post BMT and anticoagulation was discontinued. Unfortunately, his right hemiplegia persists.
Discussion
We describe a combination of unusual sequelae following BMT for Omenn syndrome and link them with a unifying hypothesis. Anticardiolipin antibodies are auto-antibodies against negatively charged phospholipids and their significance in childhood has been reviewed. 4 In the antiphospholipid syndrome their presence is associated with recurrent vascular thrombosis and there is a high prevalence of anticardiolipin antibodies in children with idiopathic cerebral ischaemia. 5 In our patient anticardiolipin antibodies appeared only after BMT, probably as a direct consequence of immune dysregulation in the early post-transplant period. The evolution of auto-reactive antibodies following BMT is well documented and the presence of anticardiolipin antibodies was recently reported in 8% of asymptomatic children screened after transplantation. 6 Multiple thrombotic events are very unusual in BMT. In this patient anticardiolipin antibodies may have precipitated the release of microemboli from the tip of his central venous line which led to pulmonary microembolism. This would explain the development of pulmonary hypertension and high right heart pressures may then have led to right- to-left transseptal shunting across a patent foramen ovale. Emboli from the venous circulation could then have directly entered the systemic circulation leading to a cerebrovascular accident in the left middle cerebral artery. Ventilation/perfusion image did not demonstrate any large mismatches but this is an insensitive technique for the detection of pulmonary embolism. 7 Echocardiography, however, has been advocated as a useful tool in childhood pulmonary embolism and relies on the indirect indices of increased right ventricular volume or pressure. 8 In this case the echocardiographic findings, along with the dramatic improvement upon removal of the line and anticoagulation, makes pulmonary embolism likely.
Recent studies suggest that central line-associated atrial thrombi 9 and pulmonary embolism 8 in children are not as unusual as previously suspected. Parenteral nutrition is known to increase the risk of such complications. 10 However, our patient required TPN for only 5 days in the immediate post-transplant period and was enterally fed thereafter. There are no published data on the relationship between anticardiolipin antibody titres and the risk of central line-derived thromboembolism in children or in adults. Having already suffered significant thromboembolic events, albeit in the context of central venous catheterisation, our patient was anticoagulated. Anticardiolipin antibody titres normalised within 4 months and anticoagulation has been stopped without further thrombotic events.
This report of a serious and devastating autoimmune complication following BMT highlights the importance of screening for anticardiolipin antibodies whenever thrombotic events are suspected. The early removal of central venous catheters in patients with elevated anticardiolipin antibody titres is advocated.
